Bangalore: Risk management should be seen as an opportunity and innovative approaches are required to address mission cr...
Over the years, some of the Asian companies have made significant breakthroughs in antibody research and are exploring f...
Singapore: Providing a final nod to 17 Foreign Direct Investment (FDI) proposals in India across various sectors, the co...
If you are unwell, you could visit a doctor, but no longer will you be taking general medication for a range of possible...
Singapore: Novartis Pharmaceuticals has reported to settle its litigation with US subsidiary of India based Sun Pharmace...
Singapore: The US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted Piramal Imagi...
For many Asian pharmaceutical companies, pharmacovigilance is a critical component of any drug development program. As p...
Bangalore: US-based Pfenex and India-based Agila Biotech, a subsidiary of Strides Arcolab, entered into a joint venture ...
Started in 1999, India-based GenAxy Scientific with its corporate office in New Delhi and head office in Solan, has made...
Entry of multinational companies has been a big boost to Asia's position in biologics manufacturing, especially with cGM...
Mumbai: Pharma major Lupin's subsidiary, Lupin Pharmaceuticals, has received final approval for its pregabalin capsules,...
The BioAgri sector has registered a record revenue of $621 million as compared to previous year's revenue of $140 millio...
LifeCell International, India's largest private stem cell bank and the first stem cell solution provider to bring the co...
New Delhi: Chandigarh-based Venus Remedies, a leading research based global pharmaceutical company secured its first pat...
Singapore: Tripura has become the first Indian state to announce its implementation of the country's health ministry's d...
Singapore: GVK Biosciences, Asia's leading contract research organization (CRO) has licensed its popular clinical bioma...
Singapore: "Make quality the top priority," was the clear message from the FDA officials to Indian Pharma companies. A ...